Monitoring the Patient Following Radio-Cephalic Arteriovenous Fistula Creation: Current Perspectives.


Journal

Vascular health and risk management
ISSN: 1178-2048
Titre abrégé: Vasc Health Risk Manag
Pays: New Zealand
ID NLM: 101273479

Informations de publication

Date de publication:
2021
Historique:
received: 21 02 2021
accepted: 19 03 2021
entrez: 15 4 2021
pubmed: 16 4 2021
medline: 30 4 2021
Statut: epublish

Résumé

Autogenous radial-cephalic direct wrist arteriovenous fistula (RC-AVF) in the non-dominant arm is the gold standard for dialysis vascular access. However, the RC-AVF non-maturation rate is significant (≃ 40%) due to an increasingly elderly and comorbid population incidence. A detailed identification of the biological cascade underlying arteriovenous fistula (AVF) maturation could be the key to clinical research aimed at identify the group of patients at risk of primary AVF failure. Currently, careful post-operative monitoring remains the most crucial aspect to overcome the problem of impaired maturation. Up to 80% of patients with immature RC-AVF have problems potentially solvable with early endovascular or surgical correction. Physical examination by experienced practitioners in conjunction with duplex ultrasound examination (DUS) can identify physical signs of non-maturation, understand the underlying cause, and drive for a tailored early planning to treat the complication. New approaches for the early assessment of AVF maturation are under study. Techniques to promote RC-AVF maturation performed through the administration of pre-or peri-operative drugs have missed up to now to prove an efficacy in improving fistula success. The new techniques tested after surgery appear to hold future promise for improving fistula maturation.

Identifiants

pubmed: 33854321
doi: 10.2147/VHRM.S205130
pii: 205130
pmc: PMC8040072
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

111-121

Informations de copyright

© 2021 Pirozzi et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

J Vasc Surg. 2007 Feb;45(2):420-426
pubmed: 17264030
J Vasc Access. 2015 Sep-Oct;16(5):364-6
pubmed: 26165813
Atherosclerosis. 2010 Jul;211(1):159-63
pubmed: 20163795
J Vasc Access. 2014;15 Suppl 7:S55-9
pubmed: 24817456
Nephrol Dial Transplant. 2002 Jun;17(6):1057-62
pubmed: 12032197
J Vasc Access. 2008 Oct-Dec;9(4):241-7
pubmed: 19085893
J Am Soc Nephrol. 2016 Dec;27(12):3508-3510
pubmed: 27493254
Quant Imaging Med Surg. 2018 May;8(4):444-446
pubmed: 29928609
Altern Ther Health Med. 2016 Sep;22(5):18-22
pubmed: 27622956
Cochrane Database Syst Rev. 2015 Sep 30;(9):CD007013
pubmed: 26418347
Am J Nephrol. 2019;50(4):320-328
pubmed: 31434095
Nutr Hosp. 2018 Jan 10;35(1):176-184
pubmed: 29565167
Nephrol Dial Transplant. 2010 Feb;25(2):520-5
pubmed: 19736247
Radiology. 2016 May;279(2):620-9
pubmed: 26694050
Semin Dial. 2008 Jan-Feb;21(1):85-8
pubmed: 18251963
Clin Nephrol. 2002 Aug;58(2):122-7
pubmed: 12227684
J Vasc Access. 2021 Mar;22(2):166-172
pubmed: 32026749
Eur J Vasc Endovasc Surg. 2004 Dec;28(6):583-9
pubmed: 15531191
Ren Fail. 2017 Nov;39(1):613-622
pubmed: 28805538
J Vasc Surg. 2015 Apr;61(4):1020-5
pubmed: 25595404
Kidney Int. 2002 Mar;61(3):1170-3
pubmed: 11849472
J Vasc Surg. 2012 Aug;56(2):440-5
pubmed: 22575481
Nephrol Dial Transplant. 2019 Jun 1;34(Suppl 2):ii1-ii42
pubmed: 31192372
J Vasc Surg. 2017 Feb;65(2):444-451
pubmed: 27986484
J Am Coll Surg. 2008 May;206(5):1076-81; discussion 1081-2
pubmed: 18471759
Am J Kidney Dis. 2020 Apr;75(4 Suppl 2):S1-S164
pubmed: 32778223
Biomed Res Int. 2015;2015:171674
pubmed: 26495286
J Vasc Surg. 2007 Apr;45(4):804-11
pubmed: 17398390
Am J Pathol. 2017 Sep;187(9):2095-2101
pubmed: 28822538
J Vasc Access. 2013 Jul-Sep;14(3):239-44
pubmed: 23283645
J Vasc Surg. 2009 Oct;50(4):953-6
pubmed: 19786244
J Vasc Surg. 2011 Nov;54(5):1383-9
pubmed: 21840154
Semin Dial. 2008 Nov-Dec;21(6):557-60
pubmed: 18764788
Am J Kidney Dis. 2000 Dec;36(6):1126-34
pubmed: 11096036
J Am Heart Assoc. 2017 Mar 30;6(4):
pubmed: 28360226
J Vasc Surg. 2009 Dec;50(6):1359-68.e1
pubmed: 19958986
Blood Purif. 2019;47(1-3):240-245
pubmed: 30522127
Nefrologia. 2016 Jul-Aug;36(4):410-7
pubmed: 26948443
Int Angiol. 2020 Dec;39(6):525-531
pubmed: 32519532
Int J Mol Sci. 2016 May 27;17(6):
pubmed: 27240348
J Vasc Access. 2017 Jan 18;18(1):3-12
pubmed: 27739573
J Vasc Surg. 2018 Jan;67(1):236-243
pubmed: 28733096
Eur J Vasc Endovasc Surg. 2018 Jun;55(6):757-818
pubmed: 29730128
Radiology. 2002 Oct;225(1):59-64
pubmed: 12354984
Clin J Am Soc Nephrol. 2011 Mar;6(3):575-81
pubmed: 21088288
Am J Kidney Dis. 2020 Jan;75(1):45-53
pubmed: 31447072
J Vasc Access. 2016 Jan-Feb;17(1):1-5
pubmed: 26660043
J Vasc Surg. 2009 Aug;50(2):369-74, 374.e1
pubmed: 19631871
Kidney Res Clin Pract. 2018 Sep;37(3):277-286
pubmed: 30254852
J Vasc Surg. 2019 Feb;69(2):507-515
pubmed: 30683197
J Vasc Access. 2017 Mar 6;18(Suppl. 1):10-14
pubmed: 28297046
Ther Apher Dial. 2016 Apr;20(2):107-11
pubmed: 27004938
Semin Dial. 2018 May;31(3):244-257
pubmed: 29178510
J Vasc Access. 2014 Jan-Feb;15(1):38-44
pubmed: 24043330
PLoS One. 2016 Nov 10;11(11):e0166362
pubmed: 27832203
J Vasc Access. 2020 Sep;21(5):554-563
pubmed: 31419923
Kidney Int Rep. 2016 Aug 27;2(1):76-79
pubmed: 29142943
J Vasc Access. 2020 Mar;21(2):134-147
pubmed: 31113281
Tech Vasc Interv Radiol. 2008 Sep;11(3):175-80
pubmed: 19100946
Nephrol Dial Transplant. 2013 Apr;28(4):997-1005
pubmed: 22785110
Open Urol Nephrol J. 2014;7(Suppl 1 M5):33-44
pubmed: 25309636
PLoS One. 2019 Mar 26;14(3):e0213274
pubmed: 30913208
Clin Hemorheol Microcirc. 2017;66(3):211-217
pubmed: 28527196
J Vasc Surg. 2002 Sep;36(3):460-3
pubmed: 12218967
PLoS One. 2015 Dec 30;10(12):e0145795
pubmed: 26716840
Clin Kidney J. 2019 Jun 01;13(2):184-187
pubmed: 32296523
Indian J Urol. 2015 Jul-Sep;31(3):240-4
pubmed: 26166969
Eur J Vasc Endovasc Surg. 2018 Feb;55(2):240-248
pubmed: 29307757
Hemodial Int. 2016 Apr;20(2):306-14
pubmed: 26486682
Kidney Int. 2003 Oct;64(4):1487-94
pubmed: 12969170
Am J Kidney Dis. 2004 Nov;44(5 Suppl 2):61-7
pubmed: 15486876
J Vasc Access. 2016 Jul 12;17(4):307-12
pubmed: 27056031
Cardiovasc Eng Technol. 2017 Sep;8(3):273-279
pubmed: 28752375

Auteurs

Nicola Pirozzi (N)

Interventional Nephrology Unit, Nephrology and Dialysis Department, CdC Nuova ITOR, Roma, Italy.

Nicoletta Mancianti (N)

Nephrology, Dialysis and Transplant Unit, University Hospital of Siena, Siena, Italy.

Jacopo Scrivano (J)

Interventional Nephrology Unit, Nephrology and Dialysis Department, CdC Nuova ITOR, Roma, Italy.

Loredana Fazzari (L)

Interventional Nephrology Unit, Nephrology and Dialysis Department, CdC Nuova ITOR, Roma, Italy.

Roberto Pirozzi (R)

Interventional Nephrology Unit, Nephrology and Dialysis Department, CdC Nuova ITOR, Roma, Italy.

Matteo Tozzi (M)

Vascular Surgery, University of Insubria - Asst Settelaghi Varese, Varese, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH